Publications

  1. Figueiral M, Paldino A, Fazzini L, Pereira NL. Genetic Biomarkers in Heart Failure: From Gene Panels to Polygenic Risk Scores. Curr Heart Fail Rep. 2024 Dec; 21 (6):554-569 Epub 2024 Oct 15
    View PubMed
  2. Stephens EH, Dearani JA, Griffeth EM, Altarabsheh SEI, Ameduri RK, Johnson JN, Burchill LJ, Miranda WR, Connolly HM, Kushwaha SS, Pereira NL, Villavicencio MA, Daly RC. Adult Congenital Heart Disease Transplantation: Does Univentricle Physiology Impact Early Mortality? Ann Thorac Surg. 2024 Nov; 118 (5):1088-1096 Epub 2024 June 29
    View PubMed
  3. Figueiral M, Paldino A, Wilke MVMB, Farris JD, Verheijen J, Giudicessi JR, Ackerman MJ, Olson JE, Arroyo J, Olson RJ, Klee EW, Pereira NL. Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study. Mayo Clin Proc. 2024 Nov; 99 (11):1732-1743 Epub 2024 Oct 10
    View PubMed
  4. Huxley S, Moriarty J, Hlatky MA, Lennon R, Bailey K, Bell M, Geller N, Lerman A, Mathew V, Rosenberg Y, Farkouh M, Rihal C, Borah B, Pereira NL. Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients. Pharmacogenomics J. 2024 Oct 8; 24 (6):32 Epub 2024 Oct 08
    View PubMed
  5. van den Broek WWA, Ingraham BS, Pereira NL, Lee CR, Cavallari LH, Swen JJ, Angiolillo DJ, Ten Berg JM. Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the Week. J Am Coll Cardiol. 2024 Sep 17; 84 (12):1107-1118
    View PubMed
  6. Galli M, Pereira N. Identifying and Overcoming Clopidogrel Resistance: Where Do We Stand? J Cardiovasc Pharmacol 2024 Sep 1; 84 (3):316-318 Epub 2024 Sept 01
    View PubMed
  7. Pereira NL, Cresci S, Angiolillo DJ, Batchelor W, Capers Q, Cavallari LH, Leifer D, Luzum JA, Roden DM, Stellos K, Turrise SL, Tuteja S. Cyp2c19 genetic testing for oral p2y12 inhibitor therapy: a scientific statement from the American Heart Association. Circulation. 2024 Aug 6; 150 (6):e129-50
  8. Ezzeddine FM, Davis NE, Pereira NL. Arrhythmogenic right ventricular cardiomyopathy masquerading as peripartum cardiomyopathy. HeartRhythm Case Rep. 2024 Jul; 10 (7):486-489 Epub 2024 May 09
    View PubMed
  9. Fatunde OA, Rattanawong P, Maleszewski JJ, Murray DR, Shen WK, Pereira NL. Brugada Syndrome in a Transplanted Heart: Implications for Organ Transplant Screening Process. Circ Genom Precis Med 2024 Jun; 17 (3):e004533 Epub 2024 Apr 23
    View PubMed
  10. Mathew RO, Sidhu MS, Rihal CS, Lennon R, El-Hajjar M, Yager N, Lyubarova R, Abdul-Nour K, Weitz S, O'Cochlain DF, Murthy V, Levisay J, Marzo K, Graham J, Dzavik V, So D, Goodman S, Rosenberg YD, Pereira N, Farkouh ME. Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y(12) Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovasc Drugs Ther. 2024 Jun; 38 (3):447-457 Epub 2022 Nov 29
    View PubMed
  11. Anand S, Alnsasra H, LeMond LM, Shrivastava S, Asleh R, Rosenbaum A, Kobrossi S, Mohananey A, Murphy K, Smith BH, Kushwaha S, Steidley DE, Clavell A, Young P, Pereira NL. Cardiac magnetic resonance imaging in heart transplant recipients with biopsy-negative graft dysfunction. ESC Heart Fail. 2024 Jun; 11 (3):1594-1601 Epub 2024 Feb 20
    View PubMed
  12. Castrichini M, De Luca A, De Angelis G, Neves R, Paldino A, Dal Ferro M, Barbati G, Medo K, Barison A, Grigoratos C, Gigli M, Stolfo D, Brun F, Groves DW, Quaife R, Eldemire R, Graw S, Addison J, Todiere G, Gueli IA, Botto N, Emdin M, Aquaro GD, Garmany R, Pereira NL, Taylor MRG, Ackerman MJ, Sinagra G, Mestroni L, Giudicessi JR, Merlo M. Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies. J Am Coll Cardiol. 2024 May 14; 83 (19):1841-1851
    View PubMed
  13. Kobashigawa J, VanWagner LB, Hall S, Emamaullee J, Entwistle JW, Ganger D, Gebel H, Jeevanandam V, Kaldas F, Kilic A, Kittleson M, Kushwaha S, Kwong A, Lui GK, Motayagheni N, Patel J, Patel N, Pereira N, Potter L, Sani M, Schiano TD, Shingina A, Consensus Conference participants. Summary of a consensus conference on heart-liver transplantation. Am J Transplant. 2024 Mar; 24 (3):380-390 Epub 2023 Dec 09
    View PubMed
  14. Avram R, Byrne J, So D, Iturriaga E, Lennon R, Murthy V, Geller N, Goodman S, Rihal C, Rosenberg Y, Bailey K, Farkouh M, Bell M, Cagin C, Chavez I, El-Hajjar M, Ginete W, Lerman A, Levisay J, Marzo K, Nazif T, Tanguay JF, Pletcher M, Marcus GM, Pereira NL, Olgin J. Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study. J Med Internet Res. 2023 Nov 10; 25:e47475
    View PubMed
  15. Liu D, Wang M, Murthy V, McNamara DM, Nguyen TTL, Philips TJ, Vyas H, Gao H, Sahni J, Starling RC, Cooper LT, Skime MK, Batzler A, Jenkins GD, Barlera S, Pileggi S, Mestroni L, Merlo M, Sinagra G, Pinet F, Krejci J, Chaloupka A, Miller JD, de Groote P, Tschumperlin DJ, Weinshilboum RM, Pereira NL. Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis. Circ Res. 2023 Oct 27; 133 (10):810-825 Epub 2023 Oct 06
    View PubMed
  16. Neves R, Tseng AS, Garmany R, Fink AL, McLeod CJ, Cooper LT, MacIntyre CJ, Homb AC, Rosenbaum AN, Bois JP, Abou Ezzeddine OF, Siontis KC, Pereira NL, Ackerman MJ, Giudicessi JR. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy. Int J Cardiol. 2023 Oct 15; 389:131173 Epub 2023 July 08
    View PubMed
  17. Castrichini M, Agboola KM, Vyas H, Abou Ezzeddine OF, Siontis KC, Giudicessi JR, Rosenbaum AN, Pereira NL. Cardiac Sarcoidosis Mimickers: Genetic Testing in Undifferentiated Inflammatory Cardiomyopathies. Circ Genom Precis Med. 2023 Oct; 16 (5):478-479 Epub 2023 July 04
    View PubMed
  18. Shabani M, Wang M, Jenkins GD, Rotter JI, Rich SS, Batzler A, Taylor KD, Mychaleckyj JC, Liu D, Lima JAC, Pereira NL. Myocardial Fibrosis and Cardiomyopathy Risk: A Genetic Link in the MESA. Circ Heart Fail. 2023 Sep; 16 (9):e010262 Epub 2023 Aug 01
    View PubMed
  19. Gui H, Tang WHW, Francke S, Li J, She R, Bazeley P, Pereira NL, Adams K, Luzum JA, Connolly TM, Hernandez AF, McNaughton CD, Williams LK, Lanfear DE. Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial. Circ Heart Fail. 2023 Sep; 16 (9):e010438 Epub 2023 July 26
    View PubMed
  20. Capodanno D, Mehran R, Krucoff MW, Baber U, Bhatt DL, Capranzano P, Collet JP, Cuisset T, De Luca G, De Luca L, Farb A, Franchi F, Gibson CM, Hahn JY, Hong MK, James S, Kastrati A, Kimura T, Lemos PA, Lopes RD, Magee A, Matsumura R, Mochizuki S, O'Donoghue ML, Pereira NL, Rao SV, Rollini F, Shirai Y, Sibbing D, Smits PC, Steg PG, Storey RF, Ten Berg J, Valgimigli M, Vranckx P, Watanabe H, Windecker S, Serruys PW, Yeh RW, Morice MC, Angiolillo DJ. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation. 2023 Jun 20; 147 (25):1933-1944 Epub 2023 June 19
    View PubMed
  21. Ng CT, Gonzalez Bonilla HM, Chang I, Aung MT, Gile JJ, Pereira NL, Villasboas Bisneto JC, Johnston PB, Villarraga HR, Rodriguez-Porcel MG, Lin G, Lin Y, Herrmann J. CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement. JACC Case Rep. 2023 Jun 7; 15:101840 Epub 2023 Apr 21
    View PubMed
  22. Saleh A, Al-Abcha A, Pereira N. Pharmacogenetics of cardiovascular drugs. Curr Opin Cardiol. 2023 May 1; 38 (3):207-214 Epub 2023 Mar 28
    View PubMed
  23. Ingraham BS, Farkouh ME, Lennon RJ, So D, Goodman SG, Geller N, Bae JH, Jeong MH, Baudhuin LM, Mathew V, Bell MR, Lerman A, Fu YP, Hasan A, Iturriaga E, Tanguay JF, Welsh RC, Rosenberg Y, Bailey K, Rihal C, Pereira NL. Genetic-Guided Oral P2Y(12) Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2023 Apr 10; 16 (7):816-825
    View PubMed
  24. Mohananey A, Tseng AS, Julakanti RR, Gonzalez-Bonilla HM, Kruisselbrink T, Prochnow C, Rodman S, Lin G, Redfield MM, Rosenbaum AN, Pereira NL. An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinic. Genet Med. 2023 Mar; 25(3):100341. Epub 2022 Dec 06.
    View PubMed
  25. Castrichini M, Luzum JA, Pereira N. Pharmacogenetics of Antiplatelet Therapy. Annu Rev Pharmacol Toxicol. 2023 Jan 20; 63:211-229 Epub 2022 Jan 08
    View PubMed
  26. Baudhuin LM, Train LJ, Goodman SG, Lane GE, Lennon RJ, Mathew V, Murthy V, Nazif TM, So DYF, Sweeney JP, Wu AHB, Rihal CS, Farkouh ME, Pereira NL. Point of care CYP2C19 genotyping after percutaneous coronary intervention. Pharmacogenomics J. 2022 Dec; 22 (5-6):303-307 Epub 2022 Apr 21
    View PubMed
  27. Kim KH, Kwon JM, Pereira T, Attia ZI, Pereira NL. Artificial Intelligence Applied to Cardiomyopathies: Is It Time for Clinical Application? Curr Cardiol Rep. 2022 Nov; 24 (11):1547-1555 Epub 2022 Sept 01
    View PubMed
  28. Gates KV, Panicker AJ, Biendarra-Tiegs SM, Vetr NG, Lopera Higuita M, Nelson TJ, Pereira NL, Griffiths LG. Shotgun Immunoproteomics for Identification of Nonhuman Leukocyte Antigens Associated With Cellular Dysfunction in Heart Transplant Rejection. Transplantation. 2022 Jul 1; 106 (7):1376-1389 Epub 2021 Dec 17
    View PubMed
  29. Madan M, Abbott JD, Lennon R, So DYF, MacDougall AM, McLaughlin MA, Murthy V, Saw J, Rihal C, Farkouh ME, Pereira NL, Goodman SG, TAILOR-PCI Investigators *. Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. J Am Heart Assoc. 2022 Jun 21; 11 (12):e024709 Epub 2022 June 14
    View PubMed
  30. Avram R, So D, Iturriaga E, Byrne J, Lennon R, Murthy V, Geller N, Goodman S, Rihal C, Rosenberg Y, Bailey K, Farkouh M, Bell M, Cagin C, Chavez I, El-Hajjar M, Ginete W, Lerman A, Levisay J, Marzo K, Nazif T, Olgin J, Pereira N. Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study. JMIR Form Res. 2022 Jun 13; 6 (6):e34080 Epub 2022 June 13
    View PubMed
  31. Nguyen TTL, Wang M, Liu D, Iyer S, Gonzalez Bonilla HM, Acker N, Murthy V, Shrivastava S, Desai V, Burnett JC Jr, Redfield M, Bailey KR, Weinshilboum RM, Pereira NL. Proteomic Biomarkers of Sacubitril/Valsartan Treatment Response in Heart Failure With Preserved Ejection Fraction: Molecular Insights Into Sex Differences. Circ Heart Fail 2022 Jun 3; 101161CIRCHEARTFAILURE122009629 Epub 2022 June 03
    View PubMed
  32. Wang L, Scherer SE, Bielinski SJ, Muzny DM, Jones LA, Black JL 3rd, Moyer AM, Giri J, Sharp RR, Matey ET, Wright JA, Oyen LJ, Nicholson WT, Wiepert M, Sullard T, Curry TB, Rohrer Vitek CR, McAllister TM, St Sauver JL, Caraballo PJ, Lazaridis KN, Venner E, Qin X, Hu J, Kovar CL, Korchina V, Walker K, Doddapaneni H, Wu TJ, Raj R, Denson S, Liu W, Chandanavelli G, Zhang L, Wang Q, Kalra D, Karow MB, Harris KJ, Sicotte H, Peterson SE, Barthel AE, Moore BE, Skierka JM, Kluge ML, Kotzer KE, Kloke K, Vander Pol JM, Marker H, Sutton JA, Kekic A, Ebenhoh A, Bierle DM, Schuh MJ, Grilli C, Erickson S, Umbreit A, Ward L, Crosby S, Nelson EA, Levey S, Elliott M, Peters SG, Pereira N, Frye M, Shamoun F, Goetz MP, Kullo IJ, Wermers R, Anderson JA, Formea CM, El Melik RM, Zeuli JD, Herges JR, Krieger CA, Hoel RW, Taraba JL, St Thomas SR, Absah I, Bernard ME, Fink SR, Gossard A, Grubbs PL, Jacobson TM, Takahashi P, Zehe SC, Buckles S, Bumgardner M, Gallagher C, Fee-Schroeder K, Nicholas NR, Powers ML, Ragab AK, Richardson DM, Stai A, Wilson J, Pacyna JE, Olson JE, Sutton EJ, Beck AT, Horrow C, Kalari KR, Larson NB, Liu H, Wang L, Lopes GS, Borah BJ, Freimuth RR, Zhu Y, Jacobson DJ, Hathcock MA, Armasu SM, McGree ME, Jiang R, Koep TH, Ross JL, Hilden MG, Bosse K, Ramey B, Searcy I, Boerwinkle E, Gibbs RA, Weinshilboum RM. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genet Med. 2022 May; 24(5):1062-1072. Epub 2022 Mar 21.
    View PubMed
  33. Galli M, Benenati S, Franchi F, Rollini F, Capodanno D, Biondi-Zoccai G, Vescovo GM, Cavallari LH, Bikdeli B, Ten Berg J, Mehran R, Gibson CM, Crea F, Pereira NL, Sibbing D, Angiolillo DJ. Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. Eur Heart J. 2022 Mar 7; 43 (10):959-967
    View PubMed
  34. Capodanno D, Angiolillo DJ, Lennon RJ, Goodman SG, Kim SW, O'Cochlain F, So DY, Sweeney J, Rihal CS, Farkouh M, Pereira NL. ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. J Am Heart Assoc. 2022 Feb 15; 11 (4):e024156 Epub 2022 Feb 08
    View PubMed
  35. Asleh R, Vucicevic D, Petterson TM, Kremers WK, Pereira NL, Daly RC, Edwards BS, Steidley DE, Scott RL, Kushwaha SS. Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study. J Clin Med. 2022 Jan 10; 11 (2)
    View PubMed
  36. Shabani M, Dutta D, Ambale-Venkatesh B, Post WS, Taylor KD, Rich SS, Wu CO, Pereira NL, Shah SJ, Chatterjee N, Rotter JI, Arking DE, Lima JAC. Rare Genetic Variants Associated With Myocardial Fibrosis: Multi-Ethnic Study of Atherosclerosis. Front Cardiovasc Med. 2022; 9:804788 Epub 2022 Feb 21
    View PubMed
  37. Parcha V, Heindl BF, Li P, Kalra R, Limdi NA, Pereira NL, Arora G, Arora P. Genotype-Guided P2Y(12) Inhibitor Therapy After Percutaneous Coronary Intervention: A Bayesian Analysis. Circ Genom Precis Med. 2021 Dec; 14 (6):e003353 Epub 2021 Oct 21
    View PubMed
  38. Gentile P, Merlo M, Peretto G, Ammirati E, Sala S, Della Bella P, Aquaro GD, Imazio M, Potena L, Campodonico J, Foa A, Raafs A, Hazebroek M, Brambatti M, Cercek AC, Nucifora G, Shrivastava S, Huang F, Schmidt M, Muser D, Van de Heyning CM, Van Craenenbroeck E, Aoki T, Sugimura K, Shimokawa H, Cannata A, Artico J, Porcari A, Colopi M, Perkan A, Bussani R, Barbati G, Garascia A, Cipriani M, Agostoni P, Pereira N, Heymans S, Adler ED, Camici PG, Frigerio M, Sinagra G. Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias. Eur J Heart Fail. 2021 Dec; 23 (12):2045-2054 Epub 2021 July 21
    View PubMed
  39. Kim KH, Pereira NL. Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure. Korean Circ J. 2021 Oct; 51 (10):797-836 Epub 2021 July 22
    View PubMed
  40. Shrivastava S, Kruisselbrink TM, Mohananey A, Thomas BC, Kushwaha SS, Pereira NL. Rare TBX4 Variant Causing Pulmonary Arterial Hypertension With Small Patella Syndrome in an Adult Man. JACC Case Rep. 2021 Sep 15; 3 (12):1447-1452 Epub 2021 Sept 15
    View PubMed
  41. Shrivastava S, Cohen-Shelly M, Attia ZI, Rosenbaum AN, Wang L, Giudicessi JR, Redfield M, Bailey K, Lopez-Jimenez F, Lin G, Kapa S, Friedman PA, Pereira NL. Artificial Intelligence-Enabled Electrocardiography to Screen Patients with Dilated Cardiomyopathy. Am J Cardiol. 2021 Sep 15; 155:121-127 Epub 2021 July 24
    View PubMed
  42. Shelly S, Talha N, Pereira NL, Engel AG, Johnson JN, Selcen D. Expanding Spectrum of Desmin-Related Myopathy, Long-term Follow-up, and Cardiac Transplantation. Neurology. 2021 Sep 14; 97 (11):e1150-e1158 Epub 2021 July 27
    View PubMed
  43. Attia ZI, Kapa S, Dugan J, Pereira N, Noseworthy PA, Jimenez FL, Cruz J, Carter RE, DeSimone DC, Signorino J, Halamka J, Chennaiah Gari NR, Madathala RS, Platonov PG, Gul F, Janssens SP, Narayan S, Upadhyay GA, Alenghat FJ, Lahiri MK, Dujardin K, Hermel M, Dominic P, Turk-Adawi K, Asaad N, Svensson A, Fernandez-Aviles F, Esakof DD, Bartunek J, Noheria A, Sridhar AR, Lanza GA, Cohoon K, Padmanabhan D, Pardo Gutierrez JA, Sinagra G, Merlo M, Zagari D, Rodriguez Escenaro BD, Pahlajani DB, Loncar G, Vukomanovic V, Jensen HK, Farkouh ME, Luescher TF, Su Ping CL, Peters NS, Friedman PA, Discover Consortium (Digital and Noninvasive Screening for COVID-19 with AI ECG Repository). Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram. Mayo Clin Proc. 2021 Aug; 96 (8):2081-2094
    View PubMed
  44. Morales-Rosado JA, Goel K, Zhang L, Akerblom A, Baheti S, Black JL, Eriksson N, Wallentin L, James S, Storey RF, Goodman SG, Jenkins GD, Eckloff BW, Bielinski SJ, Sicotte H, Johnson S, Roger VL, Wang L, Weinshilboum R, Klee EW, Rihal CS, Pereira NL. Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics. Cardiovasc Drugs Ther. 2021 Jun; 35 (3):549-559
    View PubMed
  45. Asleh R, Briasoulis A, Smith B, Lopez C, Alnsasra H, Pereira NL, Edwards BS, Clavell AL, Stulak JM, Locker C, Kremers WK, Daly RC, Lerman A, Kushwaha SS. Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation. J Card Fail. 2021 May; 27 (5):542-551
    View PubMed
  46. Pereira NL, Rihal C, Lennon R, Marcus G, Shrivastava S, Bell MR, So D, Geller N, Goodman SG, Hasan A, Lerman A, Rosenberg Y, Bailey K, Murad MH, Farkouh ME. Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y(12) Inhibitor Therapy: A Meta-Analysis. JACC Cardiovasc Interv. 2021 Apr 12; 14 (7):739-750 Epub 2021 Mar 17
    View PubMed
  47. Giudicessi JR, Shrivastava S, Ackerman MJ, Pereira NL. Clinical Impact of Secondary Risk Factors in TTN-Mediated Dilated Cardiomyopathy. Circ Genom Precis Med 2021 Apr; 14 (2):e003240 Epub 2021 Apr 19
    View PubMed
  48. Daly RC, Rosenbaum AN, Dearani JA, Clavell AL, Pereira NL, Boilson BA, Frantz RP, Behfar A, Dunlay SM, Rodeheffer RJ, Schirger JA, Taner T, Gandhi MJ, Heimbach JK, Rosen CB, Edwards BS, Kushwaha SS. Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients. J Am Coll Cardiol. 2021 Mar 16; 77 (10):1331-1340
    View PubMed
  49. Asleh R, Alnsasra H, Lerman A, Briasoulis A, Pereira NL, Edwards BS, Toya T, Stulak JM, Clavell AL, Daly RC, Kushwaha SS. Effects of mTOR inhibitor-related proteinuria on progression of cardiac allograft vasculopathy and outcomes among heart transplant recipients. Am J Transplant. 2021 Feb; 21 (2):626-635 Epub 2020 July 21
    View PubMed
  50. Pereira NL, Ahmad F, Byku M, Cummins NW, Morris AA, Owens A, Tuteja S, Cresci S. COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine. Mayo Clin Proc. 2021 Feb; 96 (2):446-463 Epub 2020 Dec 03
    View PubMed
  51. Pereira NL, Avram R, So DY, Iturriaga E, Byrne J, Lennon RJ, Murthy V, Geller N, Goodman SG, Rihal C, Rosenberg Y, Bailey K, Pletcher MJ, Marcus GM, Farkouh ME, Olgin JE. Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry. Am Heart J. 2021 Feb; 232:84-93 Epub 2020 Oct 31
    View PubMed
  52. Agboola KM, McGill T, Boilson BA, Pereira NL, Jentzer JC. The Role of Genetic Testing in the Evaluation of Dilated Cardiomyopathies. Case Rep Cardiol. 2021; 2021:6641108 Epub 2021 Mar 02
    View PubMed
  53. Pereira NL, Farkouh ME, So D, Lennon R, Geller N, Mathew V, Bell M, Bae JH, Jeong MH, Chavez I, Gordon P, Abbott JD, Cagin C, Baudhuin L, Fu YP, Goodman SG, Hasan A, Iturriaga E, Lerman A, Sidhu M, Tanguay JF, Wang L, Weinshilboum R, Welsh R, Rosenberg Y, Bailey K, Rihal C. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial. JAMA. 2020 Aug 25; 324 (8):761-771
    View PubMed
  54. Asleh R, Albitar HAH, Schettle SD, Kushwaha SS, Pereira NL, Behfar A, Stulak JM, Rodeheffer RJ, Iyer VN. Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding. J Heart Lung Transplant 2020 May; 39 (5):492-495 Epub 2020 Feb 24
    View PubMed
  55. Rosenbaum AN, Agre KE, Pereira NL. Genetics of dilated cardiomyopathy: practical implications for heart failure management. Nat Rev Cardiol. 2020 May; 17 (5):286-297 Epub 2019 Oct 11
    View PubMed
  56. Steadman JA, Stulak JM, Clavell AL, Kushwaha SS, Edwards BS, Pereira NL, Dunlay SM, Schirger JA, Frantz RP, Smith BH, Dean PG, Daly RC. Combined Heart-Kidney Transplantation: Vasoplegia is Associated with Poorer Post-Kidney Transplant Outcomes. J Heart Lung Transplant. 2020 Apr; 39 (4S):S267 Epub 2020 Mar 30
    View PubMed
  57. Asleh R, Briasoulis A, Smith B, Lopez C, Lerman A, Pereira NL, Daly RC, Kremers WK, Clavell AL, Stulak JM, Kushwaha SS. Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39 (4S):S76 Epub 2020 Mar 30
    View PubMed
  58. Lyle MA, Iyer SR, Redfield MM, Reddy YNV, Felker GM, Cappola TP, Hernandez AF, Hernandez A, Scott CG, Burnett JC Jr, Pereira NL. Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2020 Jan; 8 (1):70-80 Epub 2019 Aug 07
    View PubMed
  59. Asleh R, Alnsasra H, Daly RC, Schettle SD, Briasoulis A, Taher R, Dunlay SM, Stulak JM, Behfar A, Pereira NL, Frantz RP, Edwards BS, Clavell AL, Kushwaha SS. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices. J Am Heart Assoc. 2019 Nov 19; 8 (22):e013108 Epub 2019 Nov 08
    View PubMed
  60. Grupper A, Pereira NL. Prognostic Biomarkers for Precision Medicine in Heart Transplant: Is Galectin-3 the One? Rev Esp Cardiol (Engl Ed) 2019 Nov; 72 (11):889-891 Epub 2019 June 11
    View PubMed
  61. Cresci S, Pereira NL, Ahmad F, Byku M, de Las Fuentes L, Lanfear DE, Reilly CM, Owens AT, Wolf MJ. Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2019 Oct; 12 (10):458-485 Epub 2019 Sept 12
    View PubMed
  62. Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ. Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 Aug 26; 12 (16):1521-1537 Epub 2019 June 12
    View PubMed
  63. Alnsasra H, Asleh R, Schettle SD, Pereira NL, Frantz RP, Edwards BS, Clavell AL, Maltais S, Daly RC, Stulak JM, Rosenbaum AN, Behfar A, Kushwaha SS. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation. J Am Heart Assoc. 2019 Aug 20; 8(16):e012073. Epub 2019 Aug 14.
    View PubMed
  64. Reddy YNV, Iyer SR, Scott CG, Rodeheffer RJ, Bailey K, Jenkins G, Batzler A, Redfield MM, Burnett JC Jr, Pereira NL. Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease. J Am Heart Assoc. 2019 Aug 6; 8 (15):e012943 Epub 2019 July 26
    View PubMed
  65. Rosenbaum AN, Pereira N. Updates on the Genetic Paradigm in Heart Failure. Curr Treat Options Cardiovasc Med. 2019 Jun 28; 21 (8):37 Epub 2019 June 28
    View PubMed
  66. Asleh R, Clavell AL, Pereira NL, Smith B, Briasoulis A, Alnsasra H, Kremers WK, Habermann TM, Otley CC, Li X, Edwards BS, Stulak JM, Daly RC, Kushwaha SS. Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation. J Am Coll Cardiol. 2019 Jun 4; 73 (21):2676-2688
    View PubMed
  67. Pereira NL, So D, Bae JH, Chavez I, Jeong MH, Kim SW, Madan M, Graham J, O'Cochlain F, Pauley N, Lennon RJ, Bailey K, Hasan A, Baudhuin LM, Bell MR, Lerman A, Goodman S, Mathew V, Farkouh M, Rihal CS. International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing. Pharmacogenet Genomics. 2019 Jun; 29 (4):76-83
    View PubMed
  68. Asleh R, Schettle S, Briasoulis A, Killian JM, Stulak JM, Pereira NL, Kushwaha SS, Maltais S, Dunlay SM. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation. Mayo Clin Proc. 2019 Jun; 94 (6):1003-1014
    View PubMed
  69. Reddy YNV, Pereira NL. Nonhuman leukocyte antigen antibodies that have impact in the heart transplant patient. Curr Opin Organ Transplant. 2019 Jun; 24 (3):279-285
    View PubMed
  70. Reddy YNV, Pereira NL. Nonhuman leukocyte antigen antibodies that have impact in the heart transplant patient. Curr Opin Organ Transplant. 2019 Apr 9 Epub 2019 Apr 09
    View PubMed
  71. Pereira NL, Rihal CS, So DYF, Rosenberg Y, Lennon RJ, Mathew V, Goodman SG, Weinshilboum RM, Wang L, Baudhuin LM, Lerman A, Hasan A, Iturriaga E, Fu YP, Geller N, Bailey K, Farkouh ME. Clopidogrel Pharmacogenetics. Circ Cardiovasc Interv. 2019 Apr; 12 (4):e007811
    View PubMed
  72. Asleh R, Briasoulis A, Pereira NL, Boilson BA, Edwards BS, Adigun R, Maltais S, Daly RC, Lerman A, Kushwaha SS. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients. ESC Heart Fail. 2018 Dec; 5 (6):1118-1129 Epub 2018 July 17
    View PubMed
  73. Al-Bawardy B, Schettle SD, Gorospe E, Kee Song LMW, Pereira NL, Alexander JA, Bruining DH, Coelho-Prabhu N, Fidler JL, Mauermann WJ, Barbara DW, Dierkhising R, Rajan E. Small bowel bleeding in patients with left ventricular assist device: outcomes of conservative therapy versus balloon-assisted enteroscopy. Ann Gastroenterol. 2018 Nov-Dec; 31 (6):692-697 Epub 2018 Sept 26
    View PubMed
  74. Asleh R, Briasoulis A, Pereira NL, Edwards BS, Frantz RP, Daly RC, Lerman A, Kushwaha SS. Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant. 2018 Nov; 37 (11):1372-1380 Epub 2018 Aug 30
    View PubMed
  75. Schettle S, Schloglhofer T, Zimpfer D, Schima H, Kaufmann F, Salimbangon A, Wolforth J, Schroeder S, Hards R, Ritchie B, Staley L, Pereira N, Kushwaha S, Maltais S, Stulak J. International Analysis of LVAD Point-of-Care Versus Plasma INR: A Multicenter Study. ASAIO J. 2018 Nov/Dec; 64 (6):e161-e165
    View PubMed
  76. Asleh R, Snipelisky D, Hathcock M, Kremers W, Liu D, Batzler A, Jenkins G, Kushwaha S, Pereira NL. Genomewide association study reveals novel genetic loci associated with change in renal function in heart transplant recipients. Clin Transplant. 2018 Oct; 32 (10):e13395 Epub 2018 Oct 02
    View PubMed
  77. Grupper A, AbouEzzeddine OF, Maleszewski JJ, Grupper A, Geske JR, Kremers WK, Kushwaha SS, Pereira NL. Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients. Clin Transplant. 2018 Sep; 32 (9):e13349 Epub 2018 July 26
    View PubMed
  78. Asleh R, Prasad M, Briasoulis A, Nardi V, Adigun R, Edwards BS, Pereira NL, Daly RC, Lerman A, Kushwaha SS. Uric acid is an independent predictor of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant. 2018 Sep; 37(9):1083-1092. Epub 2018 May 01.
    View PubMed
  79. Schettle S, Bawardy BA, Asleh R, Sherazi S, Rajan E, Stulak J, Pereira N. Danazol treatment of gastrointestinal bleeding in left ventricular assist device-supported patients. J Heart Lung Transplant 2018 Aug; 37 (8):1035-1037 Epub 2018 Apr 25
    View PubMed
  80. Asleh R, Hasin T, Briasoulis A, Schettle SD, Borlaug BA, Behfar A, Pereira NL, Edwards BS, Clavell AL, Joyce LD, Maltais S, Stulak JM, Kushwaha SS. Hemodynamic Assessment of Patients With and Without Heart Failure Symptoms Supported by a Continuous-Flow Left Ventricular Assist Device. Mayo Clin Proc. 2018 Jul; 93 (7):895-903 Epub 2018 June 19
    View PubMed
  81. Musunuru K, Arora P, Cooke JP, Ferguson JF, Hershberger RE, Hickey KT, Lee JM, Lima JAC, Loscalzo J, Pereira NL, Russell MW, Shah SH, Sheikh F, Wang TJ, MacRae CA, American Heart Association Council on Genomic and Precision Medicine; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes . Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2018 Jun; 11 (6):e000046
    View PubMed
  82. Kolla KR, Maltais S, Pereira NL, Chaliki HP. Microbubbles in the Aorta and Left Ventricle of a Patient with a Left Ventricular Assist Device: A Unique Presentation of Pump Thrombosis Leading to Urgent Surgery. Cureus. 2018 Apr 11; 10 (4):e2463
    View PubMed
  83. de Denus S, Rouleau JL, Mann DL, Huggins GS, Pereira NL, Shah SH, Cappola TP, Fouodjio R, Mongrain I, Dube MP. CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction. Pharmacogenomics J. 2018 Apr; 18 (2):232-237 Epub 2017 Apr 25
    View PubMed
  84. Pereira NL, Grogan M, Dec GW. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series. J Am Coll Cardiol. 2018 Mar 13; 71 (10):1130-1148
    View PubMed
  85. Pereira NL, Grogan M, Dec GW. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series. J Am Coll Cardiol. 2018 Mar 13; 71 (10):1149-1166
    View PubMed
  86. Kashani K, Sarvottam K, Pereira NL, Barreto EF, Kennedy CC. The sarcopenia index: A novel measure of muscle mass in lung transplant candidates. Clin Transplant. 2018 Mar; 32 (3):e13182 Epub 2018 Jan 17
    View PubMed
  87. Asleh R, Briasoulis A, Kremers WK, Adigun R, Boilson BA, Pereira NL, Edwards BS, Clavell AL, Schirger JA, Rodeheffer RJ, Frantz RP, Joyce LD, Maltais S, Stulak JM, Daly RC, Tilford J, Choi WG, Lerman A, Kushwaha SS. Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients. J Am Coll Cardiol. 2018 Feb 13; 71 (6):636-650
    View PubMed
  88. Brown SA, Pereira N. Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine. J Pers Med. 2018 Jan 30; 8 (1)
    View PubMed
  89. Rosenbaum AN, Dunlay SM, Pereira NL, Allison TG, Maltais S, Stulak JM, Joyce LD, Kushwaha SS. Determinants of Improvement in Cardiopulmonary Exercise Testing After Left Ventricular Assist Device Implantation. ASAIO J. 2018 Sep/Oct; 64(5):610-615.
    View PubMed
  90. Asleh R, Briasoulis A, Schettle SD, Tchantchaleishvili V, Pereira NL, Edwards BS, Clavell AL, Maltais S, Joyce DL, Joyce LD, Daly RC, Kushwaha SS, Stulak JM. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience. Circ Heart Fail. 2017 Nov; 10 (11)
    View PubMed
  91. Wong KL, Taner T, Smith BH, Kushwaha SS, Edwards BS, Gandhi MJ, Kremers WK, Daly RC, Pereira NL. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation. Circulation 2017 Oct 3; 136 (14):1350-1352
    View PubMed
  92. Luzum JA, Pakyz RE, Elsey AR, Haidar CE, Peterson JF, Whirl-Carrillo M, Handelman SK, Palmer K, Pulley JM, Beller M, Schildcrout JS, Field JR, Weitzel KW, Cooper-DeHoff RM, Cavallari LH, O'Donnell PH, Altman RB, Pereira N, Ratain MJ, Roden DM, Embi PJ, Sadee W, Klein TE, Johnson JA, Relling MV, Wang L, Weinshilboum RM, Shuldiner AR, Freimuth RR, Pharmacogenomics Research Network Translational Pharmacogenetics Program. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems. Clin Pharmacol Ther. 2017 Sep; 102 (3):502-510 Epub 2017 June 09
    View PubMed
  93. Luis SA, Maleszewski JJ, Young PM, Schaff HV, Pereira NL. Previously Unreported in Women Galactosidase Alpha Pro409Ser Variant Is Associated With Fabry Disease. Circ Cardiovasc Genet. 2017 Aug; 10 (4):e001661
    View PubMed
  94. Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Renal Allograft Outcome After Simultaneous Heart and Kidney Transplantation. Am J Cardiol. 2017 Aug 1; 120 (3):494-499 Epub 2017 May 11
    View PubMed
  95. Hasin T, Grupper A, Dillon JJ, Maleszewski JJ, Li Z, Topilsky Y, Frantz RP, Edwards BS, Pereira NL, Maltais S, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One Year. ASAIO J. 2017 Jul/Aug; 63 (4):401-407
    View PubMed
  96. Arendt CJ, Hong JH, Daly RC, Scott C, Mehta RA, Bailey K, Pathak J, Pereira NL. Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery. Am Heart J. 2017 May; 187:70-77 Epub 2017 Feb 16
    View PubMed
  97. Snipelisky D, Park JY, Lerman A, Mulvagh S, Lin G, Pereira N, Rodriguez-Porcel M, Villarraga HR, Herrmann J. How to Develop a Cardio-Oncology Clinic. Heart Fail Clin. 2017 Apr; 13 (2):347-359
    View PubMed
  98. Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation. J Heart Lung Transplant. 2017 Mar; 36 (3):297-304 Epub 2016 Aug 18
    View PubMed
  99. Simha V, Qin S, Shah P, Smith BH, Kremers WK, Kushwaha S, Wang L, Pereira NL. Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients. J Cardiovasc Transl Res. 2017 Feb; 10 (1):9-15 Epub 2016 Dec 27
    View PubMed
  100. Nestorovic EM, Grupper A, Joyce LD, Milic NM, Stulak JM, Edwards BS, Pereira NL, Daly RC, Kushwaha SS. Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft Outcomes. Am J Cardiol. 2017 Feb 1; 119 (3):452-456 Epub 2016 Nov 01
    View PubMed
  101. Gates KV, Pereira NL, Griffiths LG. Cardiac Non-Human Leukocyte Antigen Identification: Techniques and Troubles. Front Immunol. 2017; 8:1332 Epub 2017 Oct 18
    View PubMed
  102. Qian M, Pathak J, Pereira NL, Zhai C. Temporal reflected logistic regression for probabilistic heart failure survival score prediction Proceedings - 2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017. 2017; 2017-January:410-6
  103. Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, Stegall MD, Heimbach JK, Taner T. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation. Am J Transplant. 2016 Dec; 16 (12):3522-3531 Epub 2016 June 24
    View PubMed
  104. Grupper A, Nativi-Nicolau J, Maleszewski JJ, Geske JR, Kremers WK, Edwards BS, Kushwaha SS, Pereira NL. Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction. JACC Heart Fail. 2016 Nov; 4 (11):847-856 Epub 2016 Sept 07
    View PubMed
  105. Grupper A, Nestorovic EM, Daly RC, Milic NM, Joyce LD, Stulak JM, Joyce DL, Edwards BS, Pereira NL, Kushwaha SS. Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience. Transplant Direct. 2016 Oct; 2 (10):e106 Epub 2016 Sept 13
    View PubMed
  106. Kiernan MS, Sundareswaran KS, Pham DT, Kapur NK, Pereira NL, Strueber M, Farrar DJ, DeNofrio D, Rogers JG. Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy. J Card Fail. 2016 Oct; 22 (10):797-805 Epub 2016 Jan 14
    View PubMed
  107. Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, Merlo M. Myocarditis in Clinical Practice. Mayo Clin Proc. 2016 Sep; 91 (9):1256-66 Epub 2016 July 31
    View PubMed
  108. Grupper A, Zhao YM, Sajgalik P, Joyce LD, Park SJ, Pereira NL, Stulak JM, Burnett JC Jr, Edwards BS, Daly RC, Kushwaha SS, Schirger JA. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation. Am J Cardiol. 2016 Jun 1; 117 (11):1765-70 Epub 2016 Mar 18
    View PubMed
  109. Fine NM, Park SJ, Stulak JM, Topilsky Y, Daly RC, Joyce LD, Pereira NL, Schirger JA, Edwards BS, Lin G, Kushwaha SS. Proximal thoracic aorta dimensions after continuous-flow left ventricular assist device implantation: Longitudinal changes and relation to aortic valve insufficiency. J Heart Lung Transplant. 2016 Apr; 35: (4)423-32.
    View PubMed
  110. Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet. 2016 Apr; 9 (2):185-8
    View PubMed
  111. Taslimitehrani V, Dong G, Pereira NL, Panahiazar M, Pathak J. Developing EHR-driven heart failure risk prediction models using CPXR(Log) with the probabilistic loss function. J Biomed Inform. 2016 Apr; 60:260-9 Epub 2016 Feb 01
    View PubMed
  112. Bielinski SJ, Pathak J, Carrell DS, Takahashi PY, Olson JE, Larson NB, Liu H, Sohn S, Wells QS, Denny JC, Rasmussen-Torvik LJ, Pacheco JA, Jackson KL, Lesnick TG, Gullerud RE, Decker PA, Pereira NL, Ryu E, Dart RA, Peissig P, Linneman JG, Jarvik GP, Larson EB, Bock JA, Tromp GC, de Andrade M, Roger VL. A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network. J Cardiovasc Transl Res. 2015 Nov; 8 (8):475-83 Epub 2015 July 21
    View PubMed
  113. Pereira NL, Sargent DJ, Farkouh ME, Rihal CS. Genotype-based clinical trials in cardiovascular disease. Nat Rev Cardiol. 2015 Aug; 12 (8):475-87 Epub 2015 May 05
    View PubMed
  114. Grupper A, Park SJ, Pereira NL, Schettle SD, Gerber Y, Topilsky Y, Edwards BS, Daly RC, Stulak JM, Joyce LD, Kushwaha SS. Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease. J Heart Lung Transplant. 2015 Aug; 34 (8):1042-9 Epub 2015 Mar 26
    View PubMed
  115. Pereira NL, Tosakulwong N, Scott CG, Jenkins GD, Prodduturi N, Chai Y, Olson TM, Rodeheffer RJ, Redfield MM, Weinshilboum RM, Burnett JC. Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites. Circ Cardiovasc Genet. 2015 Feb; 8 (1):141-9 Epub 2014 Dec 01
    View PubMed
  116. Panahiazar M, Taslimitehrani V, Pereira N, Pathak J. Using EHRs and Machine Learning for Heart Failure Survival Analysis. Stud Health Technol Inform. 2015; 216:40-4
    View PubMed
  117. Panahiazar M, Taslimitehrani V, Pereira NL, Pathak J. Using EHRs for Heart Failure Therapy Recommendation Using Multidimensional Patient Similarity Analytics. Stud Health Technol Inform. 2015; 210:369-73
    View PubMed
  118. Hasin T, Kushwaha SS, Lesnick TG, Kremers W, Boilson BA, Schirger JA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Jaffe AS. Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure. Am J Cardiol. 2014 Oct 15; 114 (8):1257-63 Epub 2014 Aug 01
    View PubMed
  119. Hasin T, Huebner M, Li Z, Brown D, Stulak JM, Boilson BA, Joyce L, Pereira NL, Kushwaha SS, Park SJ. Association of HeartMate II left ventricular assist device flow estimate with thermodilution cardiac output. ASAIO J. 2014 Sep-Oct; 60(5):513-8.
    View PubMed
  120. Dunlay SM, Allison TG, Pereira NL. Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation. J Card Fail. 2014 Aug; 20 (8):548-54 Epub 2014 June 02
    View PubMed
  121. Fine NM, Daly RC, Shankar N, Park SJ, Kushwaha SS, Gandhi MJ, Pereira NL. The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection. Transplantation. 2014 Jul 27; 98 (2):229-38
    View PubMed
  122. Dunlay SM, Pereira NL, Kushwaha SS. Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc. 2014 May; 89 (5):662-76 Epub 2014 Mar 29
    View PubMed
  123. Schettle SD, Pruthi RK, Pereira NL. Continuous-flow left ventricular assist devices and gastrointestinal bleeding: potential role of danazol. J Heart Lung Transplant. 2014 May; 33(5):549-50. Epub 2014 Feb 4
    View PubMed
  124. Suresh R, Grogan M, Maleszewski JJ, Pellikka PA, Hanna M, Dispenzieri A, Pereira NL. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr. 2014 Apr; 27 (4):440-7 Epub 2014 Jan 18
    View PubMed
  125. Pereira NL, Redfield MM, Scott C, Tosakulwong N, Olson TM, Bailey KR, Rodeheffer RJ, Burnett JC Jr. A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study. PLoS One. 2014; 9 (1):e85708 Epub 2014 Jan 22
    View PubMed
  126. Hasin T, Deo S, Maleszewski JJ, Topilsky Y, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Kushwaha SS, Park SJ. The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD. ASAIO J. 2014 Jan-Feb; 60(1):9-14.
    View PubMed
  127. Liang JJ, Geske JR, Boilson BA, Frantz RP, Edwards BS, Kushwaha SS, Kremers WK, Weinshilboum RM, Pereira NL. TPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation. Pharmacogenet Genomics. 2013 Dec; 23 (12):658-65
    View PubMed
  128. Fine NM, Topilsky Y, Oh JK, Hasin T, Kushwaha SS, Daly RC, Joyce LD, Stulak JM, Pereira NL, Boilson BA, Clavell AL, Edwards BS, Park SJ. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. JACC Cardiovasc Imaging. 2013 Nov; 6: (11)1129-40.
    View PubMed
  129. Shankar N, Daly R, Geske J, Kushwaha SK, Timmons M, Joyce L, Stulak J, Gandhi M, Kremers W, Park S, Pereira NL. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay. Transplantation. 2013 Aug 15; 96(3):324-30.
    View PubMed
  130. Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE, Shuldiner AR, Vesely M, Robinson SW, Ambulos N Jr, Stass SA, Kelemen MD, Brown LA, Pollin TI, Beitelshees AL, Zhao RY, Pakyz RE, Palmer K, Alestock T, O'Neill C, Maloney K, Branham A, Sewell D, Relling MV, Crews K, Hoffman J, Cross S, Haidar C, Baker D, Hicks JK, Bell G, Greeson F, Gaur A, Reiss U, Huettel A, Cheng C, Gajjar A, Pappo A, Howard S, Hudson M, Pui CH, Jeha S, Evans WE, Broeckel U, Altman RB, Gong L, Whirl-Carrillo M, Klein TE, Sadee W, Manickam K, Sweet KM, Embi PJ, Roden D, Peterson J, Denny J, Schildcrout J, Bowton E, Pulley J, Beller M, Mitchell J, Danciu I, Price L, Pereira NL, Weinshilboum R, Wang L, Johnson JA, Nelson D, Clare-Salzler M, Elsey A, Burkley B, Langaee T, Liu F, Nessl D, Dong HJ, Lesko L, Freimuth RR, Chute CG, Pharmacogenomics Research Network Translational Pharmacogenetics Program Group. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther. 2013 Aug; 94 (2):207-10 Epub 2013 Mar 19
    View PubMed
  131. Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2013 May-Jun; 22 (3):189-94 Epub 2012 Oct 24
    View PubMed
  132. Pereira NL, Lin D, Pelleymounter L, Moon I, Stilling G, Eckloff BW, Wieben ED, Redfield MM, Burnett JC Jr, Yee VC, Weinshilboum RM. Natriuretic peptide receptor-3 gene (NPR3): nonsynonymous polymorphism results in significant reduction in protein expression because of accelerated degradation. Circ Cardiovasc Genet. 2013 Apr; 6 (2):201-10 Epub 2013 Mar 14
    View PubMed
  133. Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Gandhi MJ, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation. 2013 Mar 27; 95(6):859-65.
    View PubMed
  134. Topilsky Y, Gandhi MJ, Hasin T, Voit LL, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Kushwaha SS, Lerman A, Pereira NL. Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation. 2013 Jan 27; 95 (2):389-96
    View PubMed
  135. Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013 Jan 15; 61 (2):153-63 Epub 2012 Dec 05
    View PubMed
  136. McKie PM, McCully RB, Kamath PS, Bower TC, McKusick MA, Lapyere AC, Pereira NL. Amelioration of high cardiac output and pulmonary hypertension by occlusion of congenital porto-systemic shunt. Circulation. 2012 Nov 20; 126(21):2533-4.
    View PubMed
  137. Cho YH, Deo SV, Schirger JA, Pereira NL, Stulak JM, Park SJ. Implantation of a HeartMate II left ventricular assist device via left thoracotomy. Ann Thorac Surg. 2012 Nov; 94(5):1712-4.
    View PubMed
  138. Hasin T, Topilsky Y, Kremers WK, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Joyce L, Daly R, Stulak JM, Kushwaha SS, Park SJ, Pereira NL. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol. 2012 Nov 1; 110 (9):1322-8 Epub 2012 July 21
    View PubMed
  139. Topilsky Y, Hasin T, Raichlin E, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012 Feb 07; 125: (5)708-20.
    View PubMed
  140. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012 Jan 3; 59 (1):26-36
    View PubMed
  141. Gandhi MJ, DeGoey SR, Bundy K, Kremers WK, Knauer R, Pereira N, Edwards B, Kushwaha S, Daly RC. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc. 2011 Dec; 43(10):3840-6.
    View PubMed
  142. Topilsky Y, Hasin T, Oh JK, Borgeson DD, Boilson BA, Schirger JA, Clavell AL, Frantz RP, Tsutsui R, Liu M, Maltais S, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome. Circ Cardiovasc Imaging. 2011 Nov; 4 (6):648-61 Epub 2011 Sept 21
    View PubMed
  143. Raichlin E, Al-Omari MA, Hayes CL, Edwards BS, Frantz RP, Boilson BA, Clavell AL, Rodeheffer RJ, Schirger JA, Kushwaha SS, Allison TG, Pereira NL. Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. J Heart Lung Transplant. 2011 Oct; 30(10):1153-60. Epub 2011 May 31.
    View PubMed
  144. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalan R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Mendez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011 Jul 7; 365(1):32-43.
    View PubMed
  145. Raichlin E, Kushwaha SS, Daly RC, Kremers WK, Frantz RP, Clavell AL, Rodeheffer RJ, Larson TS, Stegall MD, McGregor C, Pereira NL, Edwards BS. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplant Proc. 2011 Jun; 43(5):1871-6.
    View PubMed
  146. Saleh HK, Villarraga HR, Kane GC, Pereira NL, Raichlin E, Yu Y, Koshino Y, Kushwaha SS, Miller FA Jr, Oh JK, Pellikka PA. Normal left ventricular mechanical function and synchrony values by speckle-tracking echocardiography in the transplanted heart with normal ejection fraction. J Heart Lung Transplant. 2011 Jun; 30 (6):652-8 Epub 2010 Dec 30
    View PubMed
  147. Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail. 2011 May; 4(3):266-75. Epub 2011 Feb 08.
    View PubMed
  148. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D, Mohacsi P, Patel J, Pereira N, Platt JL, Reed EF, Reinsmoen N, Rodriguez ER, Rose ML, Russell SD, Starling R, Suciu-Foca N, Tallaj J, Taylor DO, Van Bakel A, West L, Zeevi A, Zuckermann A, Consensus Conference Participants. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011 Mar; 30(3):252-69.
    View PubMed
  149. Topilsky Y, Oh JK, Shah DK, Boilson BA, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging. 2011 Mar; 4: (3)211-22.
    View PubMed
  150. Topilsky Y, Oh JK, Atchison FW, Shah DK, Bichara VM, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echocardiogr. 2011 Feb; 24: (2)157-69.
    View PubMed
  151. Sareyyupoglu B, Boilson BA, Durham LA, McGregor CG, Daly RC, Redfield MM, Edwards BS, Frantz RP, Pereira NL, Park SJ. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices. ASAIO J. 2010 Nov-Dec; 56 (6):527-31
    View PubMed
  152. Pereira NL, Aksoy P, Moon I, Peng Y, Redfield MM, Burnett JC Jr, Wieben ED, Yee VC, Weinshilboum RM. Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation. J Mol Cell Cardiol. 2010 Nov; 49 (5):864-74 Epub 2010 Aug 06
    View PubMed
  153. Pereira NL, Park SJ, Daly RC, Kushwaha SS, Edwards WD. De novo development of eosinophilic myocarditis with left ventricular assist device support as bridge to transplant. Ann Thorac Surg. 2010 Oct; 90 (4):1345-7
    View PubMed
  154. Pereira NL, Chen D, Kushwaha SS, Park SJ. Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2010 Oct; 11 (4):503-5 Epub 2010 July 16
    View PubMed
  155. Pereira NL, Weinshilboum RM. Cardiovascular pharmacogenomics and individualized drug therapy. Nat Rev Cardiol. 2009 Oct; 6 (10):632-8 Epub 2009 Aug 25
    View PubMed
  156. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, Kushwaha SS, Edwards BS. Combined heart and liver transplantation: a single-center experience. Transplantation. 2009 Jul 27; 88 (2):219-25
    View PubMed
  157. Raichlin E, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Pereira NL, Daly RC, McGregor CG, Lerman A, Kushwaha SS. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant. 2009 Apr; 28(4):320-7.
    View PubMed
  158. Raichlin E, Villarraga HR, Chandrasekaran K, Clavell AL, Frantz RP, Kushwaha SS, Rodeheffer RJ, McGregor CG, Daly RC, Park SJ, Kremers WK, Edwards BS, Pereira NL. Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant. 2009 Jan; 9 (1):132-9 Epub 2008 Nov 27
    View PubMed
  159. Raichlin E, Chandrasekaran K, Kremers WK, Frantz RP, Clavell AL, Pereira NL, Rodeheffer RJ, Daly RC, McGregor CG, Edwards BS, Kushwaha SS. Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation. 2008 Nov 27; 86: (10)1395-400.
    View PubMed
  160. Murray DL, Pereira NL, Miller DV. An unusual presentation of post-transplant lymphoproliferative disorder mimicking vasculitis in heart transplantation. J Heart Lung Transplant. 2008 Nov; 27(11):1257-61.
    View PubMed
  161. Boilson BA, Miller DV, Pereira NL. Late allograft failure after heart transplantation: 2 unusual cases. J Heart Lung Transplant. 2008 Sep; 27(9):1050-4. Epub 2008 Jul 26.
    View PubMed
  162. Uber WE, Self SE, Van Bakel AB, Pereira NL. Acute antibody-mediated rejection following heart transplantation. Am J Transplant. 2007 Sep; 7(9):2064-74. Epub 2007 Jul 05.
    View PubMed
  163. Patel C, Shirali G, Pereira N. Left ventricular noncompaction mimicking peripartum cardiomyopathy. J Am Soc Echocardiogr. 2007 Aug; 20(8):1009.e9-12. Epub 2007 Jun 06.
    View PubMed
  164. Goodroe R, Bonnema DD, Lunsford S, Anderson P, Ryan-Baille B, Uber W, Ikonomidis J, Crumbley AJ, VanBakel A, Zile MR, Pereira N. Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients. J Heart Lung Transplant. 2007 Feb; 26(2):145-51.
    View PubMed
  165. Pereira NL, Zile MR, Harley RA, Van Bakel AB. Myocardial mechanisms causing heart failure early after cardiac transplantation. Transplant Proc. 2006 Nov; 38(9):2999-3003.
    View PubMed
  166. Craig M, Pereira NL. Right heart catheterization and risk stratification in advanced heart failure. Curr Heart Fail Rep. 2006 Sep; 3(3):143-52.
    View PubMed
  167. Baker GH, Pereira NL, Hlavacek AM, Chessa K, Shirali G. Transthoracic real-time three-dimensional echocardiography in the diagnosis and description of noncompaction of ventricular myocardium. Echocardiography. 2006 Jul; 23(6):490-4.
    View PubMed
  168. Crumbley AJ 3rd, Odom S, Van Bakel AB, Pereira N, Ikonomidis JS, Bradley S, Kratz JM, Sade RM, Uber W, Stroud MR, Crawford FA Jr. Cardiac transplantation in South Carolina: 300 transplants. J S C Med Assoc PMID 16704179. 2006 Feb; 102: (1)5-10.
  169. Peura JL, Zile MR, Feldman DS, VanBakel AB, McClure C, Uber W, Haynes H, Pereira NL. Effects of conversion from cyclosporine to tacrolimus on left ventricular structure in cardiac allograft recipients. J Heart Lung Transplant. 2005 Nov; 24(11):1969-72.
    View PubMed
  170. Siachos T, Vanbakel A, Feldman DS, Uber W, Simpson KN, Pereira NL. Silent strokes in patients with heart failure. J Card Fail. 2005 Sep; 11(7):485-9.
    View PubMed
  171. Uber WE, Uber LA, VanBakel AB, Crumbley AJ 3rd, Pereira NL, Ikonomidis JS, Feldman DS. CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications. Transplant Proc. 2004 Dec; 36(10):3245-9.
  172. Aziz TA, Pereira NL. Electrocardiographic changes simulating a myocardial infarction after cardiac transplantation. J Heart Lung Transplant. 2004 Nov; 23(11):1301-3.
    View PubMed
  173. Feldman DS, Ikonomidis JS, Uber WE, Van Bakel AB, Pereira NL, Crumbley AJ 3rd, Tann SM. Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. J Card Fail. 2004 Aug; 10(4):292-6.
    View PubMed
  174. Lepore JJ, Maroo A, Pereira NL, Ginns LC, Dec GW, Zapol WM, Bloch KD, Semigran MJ. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol. 2002 Sep 15; 90(6):677-80.
    View PubMed
  175. Wood DE, Crumbley AJ, Pereira NL. Reversible left ventricular dysfunction simulating a myocardial infarction after pericardiectomy. Heart. 2002 Aug; 88(2):183-4.
  176. Sturdivant JL, Pereira N. Sudden cardiac death in idiopathic dilated cardiomyopathy. J S C Med Assoc. 2001 Oct; 97(10):431-4.
    View PubMed
  177. Kingman A, Pereira NL. Cardiac amyloidosis. J S C Med Assoc. 2001 May; 97(5):201-6.
    View PubMed
  178. Pereira N, Parisi A, Dec GW, Choo J, Hajjar R, Gordon PC. Myocardial stunning in hyperthyroidism. Clin Cardiol. 2000 Apr; 23(4):298-300.
    View PubMed
  179. Pereira NL, Cooper G 4th. Systolic heart failure: practical implementation of standard guidelines. Clin Cornerstone. 2000; 3(2):1-12.
    View PubMed
  180. Pereira N, Klutz WS, Fox RE, Ahn KW, Travin MI. Identification of severe right ventricular dysfunction by technetium-99m-sestamibi gated SPECT imaging. J Nucl Med. 1997 Feb; 38(2):254-6.
    View PubMed